跳至主要内容
临床试验/IRCT20200921048786N1
IRCT20200921048786N1招募中3 期

Evaluation of the efficacy of the triple combination of interferon beta-1B (IFN ß-1b), chloroquine and Kaletra in the treatment and improvement of symptoms in patients with covid -19: Clinical trial.

Dezfoul University of Medical Sciences0 个研究点目标入组 82 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Individuals over 18 years of age whose covid-19 disease has been confirmed by PCR test (PCR specification of the test from the Iranian manufacturer - Pishtaz Teb and performed by molecular method) and clinically severely ill
  • o2sat below 90% despite receiving oxygen
  • Severe bilateral pulmonary involvement
  • Satisfaction to participate in the study
  • Failure to receive any medication other than the standard protocol approved by the National Corona Therapy

排除标准

  • History of drug allergies to similar compounds
  • Pregnancy and lactation
  • Infection with other microbial or viral infections
  • History of heart disease

研究者

发起方
Dezfoul University of Medical Sciences

相似试验